NATURAL KILLER/T-CELL LYMPHOMA
Clinical trials for NATURAL KILLER/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NATURAL KILLER/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for NATURAL KILLER/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized lymphoma therapy: could lower radiation be enough?
Disease control Not yet recruitingThis trial is testing a personalized approach for people with early-stage extranodal NK/T-cell lymphoma, a rare cancer of the immune system. All participants receive two cycles of induction chemotherapy (GELAD), then doctors check how well the tumor responded using a PET/CT scan …
Matched conditions: NATURAL KILLER/T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 18, 2026 06:00 UTC
-
AI model aims to predict lymphoma treatment success
Knowledge-focused Not yet recruitingThis study will develop an artificial intelligence model to predict how well patients with a rare type of lymphoma (NK/T-cell) respond to their first chemotherapy. Researchers will collect medical images and tissue samples from 100 participants to train the AI. The goal is to hel…
Matched conditions: NATURAL KILLER/T-CELL LYMPHOMA
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC